FDA Inspection
Bushu Pharmaceuticals Ltd.Bushu Pharmaceuticals Ltd. – FDA Inspection, Dec 2, 2022
Record Details
This FDA Inspection record concerns Bushu Pharmaceuticals Ltd., with an inspection on December 2, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Bushu Pharmaceuticals Ltd.
- Inspection Date
- December 2, 2022
- Product Type
- Drugs
View Company Profile
ID · 6722d13b-13c4-4116-b99b-8f298a139476
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1194145
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.160(a)Following/documenting laboratory controls
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.42(c)Defined areas of adequate size for operations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bushu Pharmaceuticals Ltd.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 3, 2026 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| September 16, 2016 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| October 25, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 15, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bushu Pharmaceuticals Ltd.
- FDA Inspection 1329094 - 2026-08-03
- FDA Inspection 988027 - 2016-09-16
- FDA Inspection 856985 - 2013-10-25
- FDA Inspection 676806 - 2010-07-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.